Just in from Cannabiz in a piece of news that is entirely unsurprising if one knows one’s history of state testing regimes in the US.
Or to quote writer and philosopher George Santayana.
“Those who cannot remember the past are condemned to repeat it.”
EXCLUSIVE: Three medicinal cannabis products publicly named by the Therapeutic Goods Administration as having failed to comply with required standards have been exonerated by third party analysis in a development that will increase pressure to produce standardised lab testing across Australia.
The disparity in test results will also concern the TGA which in September stated that five products were found to be stronger or weaker than permitted under Therapeutic Goods Order 93 (TGO93) regulations.
Read their full report at https://www.cannabiz.com.au/calls-grow-for-uniform-lab-testing-as-third-party-analysis-exonerates-products-failed-by-the-tga/?utm_medium=email&utm_campaign=Cannabiz%20newsletter%20101220&utm_content=Cannabiz%20newsletter%20101220+CID_3dcd8902cc119a0c40cb196c371e0726&utm_source=CampaignMonitor&utm_term=Read%20more
Over 5 years we have collected a slew of stories on the issue from the US so this development, as we say above, is entirely unsurprising. Here’s a short selection
Washington State Liquor and Cannabis Board’s adoption of rules regarding Marijuana Lab Testing and Quality
California: Bureau Of Cannabis Control – Two More Notices This Morning “Medical Cannabis Testing Laboratories” & “Medical Cannabis Regulation”
California: City of Santa Rosa Medical Cannabis FAQ’s Re Cultivation, Dispensary , Manufacturing, Testing, Distro & Transportation – PEDP_Medical_Cannabis_FAQs
Oregon – OLCC Press Release: OLCC Licenses First Labs, Processors for Recreational Marijuana Market Labs Certified to Meet Stringent Testing Standards